SCHEMBL25820643

SCHEMBL25820643

Cc1c(Nc2ccnc3ccc(F)cc23)cccc1C(=O)Nc1cccc(Nc2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 7/20 0.54
CDK8 P49336 2/20 0.51
CCNC P24863 1/20 0.51
DNMT3A Q9Y6K1 5/20 0.47
DNMT3L Q9UJW3 4/20 0.45
EHMT1 Q9H9B1 2/20 0.44
EGFR P00533 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.42
ESR1 P03372 1/20 0.42
MAPK10 P53779 1/20 0.42
MAPK14 Q16539 1/20 0.42
MAPKAPK2 P49137 1/20 0.41
GAK O14976 1/20 0.41
CLK2 P49760 1/20 0.41
ACVR1 Q04771 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
DYRK1B Q9Y463 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30290776 0.94 DNMT1 (0.50) DNMT1CDK8CCNCDNMT3ADNMT3L
SCHEMBL24010231 0.94 DNMT1 (0.50) DNMT1CDK8CCNCDNMT3ADNMT3L
SCHEMBL25820663 0.90 CDK8 (0.53) DNMT1CDK8CCNCDNMT3ADNMT3L
SCHEMBL24006007 0.89 DNMT1 (0.52) DNMT1CDK8CCNCDNMT3ADNMT3L
SCHEMBL25820641 0.87 DNMT1 (0.52) DNMT1CDK8CCNCDNMT3ADNMT3L
SCHEMBL25820606 0.86 DNMT1 (0.51) DNMT1CDK8CCNCDNMT3ADNMT3L
SCHEMBL24010928 0.85 USP2 (0.49) DNMT1CDK8CCNCDNMT3ADNMT3L
SCHEMBL30290913 0.85 USP2 (0.49) DNMT1CDK8CCNCDNMT3ADNMT3L
SCHEMBL25820661 0.85 DNMT1 (0.53) DNMT1CDK8CCNCDNMT3ADNMT3L
SCHEMBL25820637 0.84 DNMT1 (0.53) DNMT1CDK8CCNCDNMT3ADNMT3L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885CDK8 385/4885CCNC 491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.